Founders From the Incumbent: An Asset and a Liability

← Back to All Insights

The strongest domain expertise on a cap table often arrives with the longest legal shadow.

A founding team out of the category leader — the ex-Medtronic regulatory lead, the ex-Boston Scientific design engineer, the diagnostics team from the reference-lab incumbent — is one of the most attractive signals in early-stage medtech. It is also a risk that is easy to under-examine. The same résumé that de-risks execution can hand a competitor's lawyers a roadmap. Underwriting only the upside ("great team") or only the downside ("litigation risk") both misread the situation. The job is to price both.

The asset is real, and it's under-credited

Operator knowledge from an incumbent is not interchangeable with a strong CV. A team that has actually shepherded a Class III device through PMA knows where the FDA conversation gets hard, how a design-history file has to be built to survive an audit, and where manufacturing scale-up quietly breaks. They carry KOL relationships and a felt sense of how a market adopts. First-time founders can be brilliant and still spend two years learning what this team already knows in their hands. That head start is a legitimate value driver, and it deserves more than a bullet point in diligence.

The liability is four exposures a competitor knows how to use

1. Invention ownership

Most employment agreements assign inventions conceived during employment to the employer. If the core idea was conceived — or reduced to practice — while a founder was still at the prior company, ownership of the startup's foundational IP is contestable. The diligence questions are concrete: when and where was the idea conceived, and is there documentation that establishes it independently of the prior employer's time and resources?

2. Trade secrets

The federal Defend Trade Secrets Act of 2016 gives a former employer a civil claim for misappropriation. The Act itself limits injunctions: a court may not prevent a person from entering an employment relationship, and any conditions on that employment must rest on evidence of threatened misappropriation, not merely on what the person knows. “Inevitable disclosure” theories, which argue that a departing employee cannot help but use what they know, therefore run mainly through state law, where courts differ on them. A device startup built by ex-competitor engineers is a natural target, and a suit does not have to succeed to do damage: the threat alone can slow a financing or a deal.

3. Non-competes and non-solicits

Enforceability is now largely a matter of state law. The FTC's attempted nationwide ban was struck down in federal court, the Commission dropped its appeals in September 2025, and the rule was formally removed from the Code of Federal Regulations effective February 12, 2026; the FTC has said it can still challenge particular non-competes case by case. California voids employee non-competes outright (Business & Professions Code §16600), and most other states enforce “reasonable” ones, but the lines keep moving. In 2026, Utah barred non-competes for licensed health care workers, Tennessee barred them for employees earning under $70,000, Virginia extended its ban to licensed health care workers, and Washington enacted a near-total ban that takes effect June 30, 2027. The founder's state of residence, and the prior employer's, can change the answer entirely.

4. Provenance and clean-room hygiene

Did the team build fresh, or carry over documents, designs, source code, or customer lists? A disciplined clean-room process — documented independent development, no imported files, counsel-reviewed at formation — is the difference between a defensible startup and a lawsuit waiting for a trigger.

Diligencing both sides

• Read the founders' invention-assignment and confidentiality agreements from the prior employer — not just their LinkedIn tenure.
• Establish the conception timeline for the core IP, with documentation independent of the prior job.
• Confirm a clean-room formation process and whether counsel ran a freedom-to-operate and trade-secret review.
• Check non-compete enforceability against the relevant states, post-FTC-rule.
• Look at the prior employer's litigation history — some incumbents have a record of suing departing teams, and that pattern is a risk factor in itself.

An incumbent pedigree is simultaneously the best reason to believe in a team and the clearest place a deal can be blown up. Both facts are true at once, and a serious diligence read prices both.

At Vantage, this is a deliberately dual read: a full report credits real operator depth from a comparable company and surfaces the invention-ownership, trade-secret and non-compete questions that come attached, each cited to its source, framed as a question for your counsel, and explicitly not legal advice.

Read the Team — and the Shadow

A full Vantage report reads a team's prior-company record and surfaces IP, trade-secret and non-compete questions worth taking to counsel, each cited to its source.

Book a Free 20-Minute Call See a Sample Report